Thijs Bressers @Tbressers@qoto.org

RT @Laura_Spagnolo_
And here's our latest preprint, on work done as a wonderful collaboration with @mfwhite2: https://biorxiv.org/cgi/content/short/2022.11.14.516469v1 #CRISPR @biorxivpreprint

RT @Barandunlab
Very excited to share our latest published #cryoEM work on the #microsporidian #proteasome with all its proteolytic sites inhibited simultaneously by a PI31-like peptide!! Fantastic job from Nathan, Kai, Rahel, and Dennis, and collaboration with Charlie (@CT_CAES)!

RT @DavideCalebiro
Very happy to share the preprint of our new single-molecule study on b-arrestin. Great work by Jak, Zsombor and Yann in the team, with amazing international collaborators! More soon… https://www.biorxiv.org/content/10.1101/2022.11.15.516577v1

RT @bjorkmanlab
We have published a new paper! Congratulations to Chengcheng Fan et al. on characterizing monoclonal antibodies elicited by a mosaic-8 RBD-nanoparticle vaccine, which demonstrated cross-reactive binding, neutralization, and targeted desired epitopes. https://www.sciencedirect.com/science/article/pii/S107476132200560X

RT @A_Shenol
1/3 Check this out! Our groups @Metabolcenter,have discovered a new class of dual-acting FFAR1/FFAR4 agonists.
Optimization of First-in-Class Dual-Acting FFAR1/FFAR4 Allosteric Modulators with Novel Mode of Action https://pubs.acs.org/doi/10.1021/acsmedchemlett.2c00160#.Y3DcaFInDos.twitter

RT @eecchemistry
Exciting collaborative work looking at how PBPs bind to beta-lactones with the Ambrose and Dessen groups! We made the cover at ACS Chem Bio! @UMNChemistry @UMN_MedChem
https://pubs.acs.org/doi/10.1021/acschembio.2c00503